Services > Feed-O-Matic > 107883 🔗

Thursday 8 April 2021 05:04

Covid-19: Italy recommends AstraZeneca vaccine for over-60s only

AstraZeneca vaccine benefits outweigh risks says EMA.From now on Italy will recommend the AstraZeneca covid-19 vaccine only for people aged over 60, the head of the nation's Superior Health Institute (ISS) Franco Locatelli announced on 7 April.The decision by Italy's health minister Roberto Speranza, following consultation with experts, comes after the European Medicines Agency (EMA) found a "possible link" between the vaccine and "very rare cases" of blood clots. Covid-19: Italy to resume AstraZeneca vaccinations The EMA reached its conclusion after a review of 62 blood-clotting cases in Europe, 18 of which were fatal. However the regulator continues to maintain that the vaccine's benefits outweigh the risks of side-effects. AstraZeneca: Italy 'right to be cautious' says health minister Locatelli told reporters that people in Italy who have already had their first dose of AstraZeneca could go ahead and receive their second dose, underlining that the government was not prohibiting the vaccine's use for under-60s. Italy originally limited AstraZeneca to people under the age of 65 - Reuters reports - however on 8 March the Italian health ministry said it could also be administered to over-65s. Italy suspends AstraZeneca covid vaccine To date Italy has approved four covid-19 vaccines: Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson, with the latter expected to arrive in mid-April. For official information relating to the covid-19 situation in Italy see the health ministry website.

read the news on Wanted in Rome - News in Italy - Rome's local English news



From now on Italy will recommend the AstraZeneca
covid-19
vaccine only for people aged over 60, the head of the nation's Superior Health Institute (ISS) Franco Locatelli announced on 7 April.
The decision by Italy's health minister Roberto Speranza, following consultation with experts, comes after the European Medicines Agency (EMA) found a "possible link" between the vaccine and "very rare cases" of blood clots.
  • Covid-19: Italy to resume AstraZeneca vaccinations
The EMA reached its conclusion after a review of 62 blood-clotting cases in Europe, 18 of which were fatal. However the regulator continues to maintain that the vaccine's benefits outweigh the risks of side-effects.
  • AstraZeneca: Italy 'right to be cautious' says health minister
Locatelli told reporters that people in Italy who have already had their first dose of AstraZeneca could go ahead and receive their second dose, underlining that the government was not prohibiting the vaccine's use for under-60s.
Italy originally limited AstraZeneca to people under the age of 65 - Reuters reports - however on 8 March the Italian health ministry said it could also be administered to over-65s.
  • Italy suspends AstraZeneca covid vaccine
To date Italy has approved four covid-19 vaccines: Pfizer-BioNTech, Moderna, AstraZeneca and
Johnson & Johnson
, with the latter expected to arrive in mid-April.
For official information relating to the covid-19 situation in Italy see the 
health ministry website
.
This site uses technical cookies, including from third parties, to improve the services offered and optimize the user experience. Please read the privacy policy. By closing this banner you accept the privacy conditions and consent to the use of cookies.
CLOSE